Delivery Order SPE2DE24DA017-SPE2D626F3612
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order for FIBERSTITCH 1.5, CURVED on June 2, 2025, with a ceiling value of $3,631.32 and an ultimate completion date of June 5, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, which supports the Department of Defense's healthcare procurement needs. The award carries no set-aside...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,837.44 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 7, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award for the delivery of orthopedic implant systems, surgical instruments, and related technologies. The delivery order falls under Arthrex's...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $5,798.10 on August 3, 2025, for Fiberstitch Implant, Curved products. This fixed-price delivery order with economic price adjustment will be performed in Naples, Florida, with an ultimate completion date of August 15, 2025. The award was made by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $4,290 by the Defense Logistics Agency's Medical Supply Chain on June 12, 2025, with an ultimate completion date of June 27, 2025. This delivery order was issued under Arthrex's existing Indefinite Delivery Contract (IDC) SPE2DE24D0020, a single-award vehicle valued at $471.0 million and running through September 1, 2029. The award carries no set-aside designation...
- Arthrex Inc., a leading developer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $31,925.38 on April 29, 2025, by the Defense Logistics Agency's Medical Supply Chain. The delivery order, designated as contract 4568083791, covers a Fibertak Springbridge Implant System with Bone Screw and Swivel Lock components and is classified as a fixed-price contract with economic price adjustment provisions. Performance is...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,072.50 for a Fibertak Disposables Curved Kit by the Defense Logistics Agency's Medical Supply Chain on May 20, 2025. The award is structured as a fixed price contract with economic price adjustment provisions and does not utilize any set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,355.54 for Fibertak biceps implants on June 4, 2025, with an ultimate completion date of June 9, 2025. The contract is fixed-price with economic price adjustment provisions and carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal healthcare marketplace. The work will be performed in Naples, Florida, and is...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $34,145.28 delivery order by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 8, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provision, calls for the delivery of a Fibertak Spondylrg Implant System with Back Swivel component to support orthopedic surgical capabilities....
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,257.22 fixed-price delivery order on September 16, 2025, for an implant system secondary fixation bioscaffold measuring 4.75x19.1 millimeters. This delivery order, with an ultimate completion date of September 19, 2025, was issued under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain, a defense-affiliated federal agency. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $20,892.87 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for FIBERSTITCH 1.5, CURVED orthopedic surgical products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 2, 2025. This award represents one of numerous task orders issued under...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F3612Delivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,089.00 for Fiberstitch Implant, Reverse Curve products on October 21, 2025. This fixed-price contract with economic price adjustment is scheduled for completion by October 24, 2025, and represents direct procurement under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The award carries no set-aside designation, reflecting Arthrex's competitive position as a sole-source supplier of specialized orthopedic implants to federal healthcare systems. Performance will occur at Arthrex's Naples, Florida facility, with funding provided through the Department of Defense Medical Supply Chain supporting military and veteran healthcare needs. This delivery order is issued under Arthrex's comprehensive IDC valued at approximately $471 million and effective through September 1, 2029, which authorizes procurement of orthopedic surgical implants, instruments, and biologics across the Department of Veterans Affairs and Department of Defense healthcare enterprise. The contract streamlines access to Arthrex's full orthopedic product portfolio, including joint replacement systems, arthroscopic instruments, and advanced biologic solutions, enabling rapid procurement for multiple Veterans Integrated Service Networks and military medical facilities nationwide. As a prime contractor, Arthrex fulfills government requirements independently without subcontractors, demonstrating its established capability to serve as the primary supplier of advanced orthopedic solutions to the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/21/25 |